/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

H

H. Küpper

AbbVie (Germany)(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

229

Papers

7.7K

Citations

40

h-index

70

i10-index

H. Küpper is an academic researcher from AbbVie (Germany). The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Autoimmune and Inflammatory Disorders Research & Spondyloarthritis Studies and Treatments. The author has an h-index of 40, co-authored 195 publications.

Research Topics

Rheumatoid Arthritis Research and Therapies Autoimmune and Inflammatory Disorders Research Spondyloarthritis Studies and Treatments Chronic Lymphocytic Leukemia Research Systemic Lupus Erythematosus Research

Papers by this author

works

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

2009 · Arthritis Research & Therapy · 406 citations

https://doi.org/10.1186/ar2794

Désirée van der Heijde David Salonen Barbara N. Weissman Robert Landewé

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study

2012 · Annals of the Rheumatic Diseases · 219 citations

https://doi.org/10.1136/annrheumdis-2011-201247

Arthur Kavanaugh Roy Fleischmann Paul Emery H. Küpper

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy

2010 · Arthritis Research & Therapy · 110 citations

https://doi.org/10.1186/ar3054

Martín Rudwaleit Filip Van den Bosch Martina Kron S. Kary

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis

2009 · Arthritis Research & Therapy · 88 citations

https://doi.org/10.1186/ar2790

Désirée van der Heijde Dennis A. Revicki Katherine Gooch Robert Wong

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

2008 · Clinical Rheumatology · 83 citations

https://doi.org/10.1007/s10067-008-0866-4

A. E. van der Bijl Ferdinand C. Breedveld Christian Antoni Joachim R. Kalden

Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan

2012 · Clinical Rheumatology · 76 citations

https://doi.org/10.1007/s10067-012-2082-5

Tomoyuki Imagawa Syuji Takei Hiroaki Umebayashi Kenichi Yamaguchi

Research topics

topics

Rheumatoid Arthritis Research and Therapies

Autoimmune and Inflammatory Disorders Research

Spondyloarthritis Studies and Treatments

Chronic Lymphocytic Leukemia Research

Systemic Lupus Erythematosus Research

Chat about Author

Papers

Chat

Click to start Chat